MY8600577A - Heterocylic compounds - Google Patents

Heterocylic compounds

Info

Publication number
MY8600577A
MY8600577A MY577/86A MY8600577A MY8600577A MY 8600577 A MY8600577 A MY 8600577A MY 577/86 A MY577/86 A MY 577/86A MY 8600577 A MY8600577 A MY 8600577A MY 8600577 A MY8600577 A MY 8600577A
Authority
MY
Malaysia
Prior art keywords
heterocylic compounds
heterocylic
compounds
Prior art date
Application number
MY577/86A
Other languages
English (en)
Inventor
Michael Dennis Dowle
Keith Mills
David Edmund Bays
Ian Harold Coates
Colin Frederick Webb
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MY8600577A publication Critical patent/MY8600577A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
MY577/86A 1980-08-12 1986-12-30 Heterocylic compounds MY8600577A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026288 1980-08-12

Publications (1)

Publication Number Publication Date
MY8600577A true MY8600577A (en) 1986-12-31

Family

ID=10515412

Family Applications (1)

Application Number Title Priority Date Filing Date
MY577/86A MY8600577A (en) 1980-08-12 1986-12-30 Heterocylic compounds

Country Status (28)

Country Link
US (2) US4672067A (no)
JP (1) JPS5759864A (no)
AR (1) AR231533A1 (no)
AT (1) AT381304B (no)
AU (1) AU548270B2 (no)
BE (1) BE889930A (no)
CA (2) CA1169429A (no)
CH (1) CH651550A5 (no)
DE (1) DE3131748A1 (no)
DK (1) DK157680C (no)
ES (2) ES504695A0 (no)
FI (1) FI812475L (no)
FR (1) FR2488605A1 (no)
GB (1) GB2081717B (no)
GR (1) GR74536B (no)
IE (1) IE51492B1 (no)
IL (1) IL63541A (no)
IT (1) IT1171451B (no)
LU (1) LU83546A1 (no)
MY (1) MY8600577A (no)
NL (1) NL8103768A (no)
NO (1) NO812722L (no)
NZ (1) NZ197997A (no)
PH (1) PH17428A (no)
PT (1) PT73503B (no)
SE (1) SE454881B (no)
ZA (1) ZA815539B (no)
ZW (1) ZW19381A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
GB8615599D0 (en) * 1986-06-26 1986-07-30 Glaxo Group Ltd Chemical compounds
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
IL114690A (en) * 1990-06-07 1997-02-18 Wellcome Found Antimigraine oxazolidinone substituted indole derivatives
GB9022250D0 (en) * 1990-10-12 1990-11-28 Glaxo Group Ltd Medicaments
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
KR0179053B1 (ko) * 1990-10-15 1999-03-20 알렌 제이.스피겔 인돌 유도체
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
ES2033577B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores.
ES2033578B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
ATE170836T1 (de) * 1993-08-31 1998-09-15 Pfizer 5-arylindolderivate
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5942536A (en) * 1995-10-10 1999-08-24 Eli Lilly And Company N- 2-substituted-3-(2-aminoethyl)-1H-indol-5-YL!-Amides: new 5-HT1F agonists
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
WO2002083771A1 (fr) * 2001-04-13 2002-10-24 Organo Corporation Echangeur d'ions
BRPI0607517A2 (pt) * 2005-04-13 2009-09-08 Neuraxon Inc compostos de indol substituìdo, composição farmacêutica compreendendo o mesmo, método para tratar e uso do mesmo
AU2016287582B2 (en) 2015-07-02 2020-03-12 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870162A (en) * 1954-04-28 1959-01-20 Upjohn Co Production of certain tryptamines and compounds produced in the process
BE632051A (fr) * 1963-05-08 1963-11-18 Sandoz Sa Nouveaux dérivés de l'indole et leur préparation.
CH442303A (de) * 1964-06-26 1967-08-31 Sandoz Ag Verfahren zur Herstellung von neuen Indol-Derivaten
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4180509A (en) * 1977-07-01 1979-12-25 Merrell Toraude Et Compagnie α-Ethynyl tryptophanes
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
ES8300700A1 (es) 1982-11-01
PT73503B (en) 1983-09-14
DE3131748A1 (de) 1982-04-01
SE8104782L (sv) 1982-02-13
JPS5759864A (en) 1982-04-10
AU548270B2 (en) 1985-12-05
US4636521A (en) 1987-01-13
NL8103768A (nl) 1982-03-01
IE811831L (en) 1982-02-12
AT381304B (de) 1986-09-25
AR231533A1 (es) 1984-12-28
CA1169429A (en) 1984-06-19
DK357181A (da) 1982-02-13
PT73503A (en) 1981-09-01
FR2488605A1 (fr) 1982-02-19
GR74536B (no) 1984-06-29
JPH0148895B2 (no) 1989-10-20
DK157680B (da) 1990-02-05
US4672067A (en) 1987-06-09
IT1171451B (it) 1987-06-10
IT8149086A0 (it) 1981-08-11
LU83546A1 (fr) 1983-06-08
ES513935A0 (es) 1984-04-16
IE51492B1 (en) 1987-01-07
DE3131748C2 (no) 1992-04-23
GB2081717B (en) 1983-09-28
ES504695A0 (es) 1982-11-01
BE889930A (fr) 1982-02-11
SE454881B (sv) 1988-06-06
CH651550A5 (fr) 1985-09-30
FI812475L (fi) 1982-02-13
PH17428A (en) 1984-08-20
ZA815539B (en) 1983-03-30
ZW19381A1 (en) 1983-03-09
DK157680C (da) 1990-07-09
NO812722L (no) 1982-02-15
IL63541A (en) 1985-08-30
FR2488605B1 (no) 1984-11-16
CA1169077A (en) 1984-06-12
ES8404327A1 (es) 1984-04-16
AU7399681A (en) 1982-02-18
NZ197997A (en) 1985-08-16
GB2081717A (en) 1982-02-24
ATA352881A (de) 1986-02-15

Similar Documents

Publication Publication Date Title
MY8600577A (en) Heterocylic compounds
SG69286G (en) 4-chlorothiazolyl-containing compounds
ZA831912B (en) Novel compounds
JPS5767568A (en) Benzisoselenazolone compound
JPS57120588A (en) Nortropanol compound
DE3171475D1 (en) Aryl-phenyl-acetylene compounds
JPS57120575A (en) Imidazolylphenylamidine compound
PT75620B (en) Novel compounds
JPS5724328A (en) Dienylmethacrylate compound
PT74377A (en) Novel compounds
GB2083046B (en) Bestatin-related compounds
PT72752A (en) Compounds
JPS56152469A (en) Substituted triarylthiazole compound
GB2067992B (en) Malonamidooxadethiacephem compounds
JPS5749666A (en) Helichromic compound
DE3162041D1 (en) Hydrouracil compounds
JPS56125389A (en) Spiro-dihydrobenzofuran compound
JPS5794051A (en) Halotriazinyl-containing compound
ZA83691B (en) Novel benzapyran compounds
GB2082577B (en) Polyazaheterocyclic compounds
ZA812675B (en) Mycotoxin-binding compound
DE3160271D1 (en) Monoalkyl-fluorotin compounds
JPS5795972A (en) 2-guanidino-4-heteroarylthiazole compound
JPS5785396A (en) 4-carbamoyloxy-oxazaphosphorine compound
ZA825525B (en) Novel compounds